期刊文献+

Effects of cytotoxic T lymphocytes on hepatoma cell line SMMC-7721 induced by different subsets of dendritic cells in vitro 被引量:4

Effects of cytotoxic T lymphocytes on hepatoma cell line SMMC-7721 induced by different subsets of dendritic cells in vitro
在线阅读 下载PDF
导出
摘要 BACKGROUND: Dendritic cells (DCs) loaded with complex antigen are always used to induce cytotoxic T lymphocytes (CTLs) which have a specific anti-tumor activity. However, CTLs can assault autologous cells induced by DCs loaded with autologous antigen. This study aimed to explore how to weaken the autoimmune reaction induced by DC vaccine by combining mature DC (mDC) activating immunity and immature DC (imDC) leading to immune tolerance to make hepatocellular carcinoma (HCC) vaccine in vitro. METHODS: DC progenitors derived from human peripheral blood were assigned to two groups. One was cultured to mDC and pulsed with frozen-thawed antigen (FTA) of human HCC cell line SMMC-7721 cells (mDC group), and the other was cultured to imDC and pulsed with FTA of human liver cell line L-02 cells (imDC group). The morphology of DCs was monitored and cells phenotypes including HLA-DR, CD80, CD1α, CD83 were assayed by flowcytometry (FCM). The concentrations of interleukin-12 (IL-12) in the supernatant were assayed by ELISA. Methyl thiazolyl tetrazolium (MTT) was used to evaluate T cell proliferation induced by mDC and imDC and the killing rate of CTL induced by mDC and imDC respectively/together on SMMC-7721 and L-02 cells. RESULTS: Compared with the imDC group, the mDC group was characterized by the following: increased secretion of IL-12 (P【0.05); higher expression of HLA-DR, CDla, CD80, CD83; and stronger activity in stimulating proliferation of isogenic T cells (P【0.05). CTL induced by the mDC group had a significant killing response to SMMC-7721 as well as a higher killing rate for L-02 (P】0.05). CTL induced by mDC and imDC together had a higher killing response to SMMC-7721, but a lower killing rate for L-02(P【0.01). CONCLUSIONS: CTL induced by mDC and imDC together has a higher antigen-specific killing response in vitro than that induced by mDC alone. This may be of greater clinical value.
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2006年第3期422-427,共6页 国际肝胆胰疾病杂志(英文版)
  • 相关文献

参考文献7

二级参考文献42

  • 1Halamay K E, Kirkman R L, Sun L, et al. CD8 T cells are sufficient to mediate allorecognition and allograft rejection[J]. Cell Immunol, 2002,216(1-2): 6-14.
  • 2Arpinati M, Terragna C, Chimmbolo G, et al. Human CD34+ blood cellsinduce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade[J]. Exp Haematol, 2003,31 ( 1 ) :31 - 38.
  • 3Talmor M, Mirza A, Turley S, et al. Generation or large numbers of immature and mature dendritic cells from rat bone marrow cultures[J]. Eur J Immunol, 1998,28(3) :811 - 817.
  • 4Nouri Shirazi M, Guinet E. Direct and indirect cross-tolerance of alloreactire T cells by dendritic cells retained in the immature stage[J]. Transplantation, 2002,74(7) : 1035 - 1044.
  • 5Bergui L, Schena M, Gaidano G, et al. Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma [ J ]. J Exp Med, 1989, 170(2):613-618.
  • 6Caux C, Vanbervliet B, Massacrier C,et al. CD34 + hematopoietic piogenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNF-αt[ J]. J Exp Med, 1996, 184: 695-706.
  • 7Yang S, Darrow TL, Vervaert CE, et al. Immuootherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow[J]. Cell Immunol, 1997, 179( 1 ): 84 -95 .
  • 8Pfeiffer S, Gooding RP, Apperley JF,et al. Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors[J]. BrJ Haematol, 1997, 98(4): 973-982.
  • 9Wen Y J, Min R, Tricot G, et al. Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immumotherapy[J]. Blood, 2002, 99(9): 3 280-3 285.
  • 10Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature, 1998 ,392 ( 6673 ) :245 - 252.

共引文献37

同被引文献29

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部